Home › NDC Lookup › RxCUI directory › RxCUI 313036

Sodium fluoride 1.1 MG Chewable Tablet — RxCUI 313036

RxNorm drug concept · Semantic clinical drug
RxCUI 313036 Semantic clinical drug · SCD ● Current RxNorm concept 9 FDA products 11 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI313036
Official nameSodium fluoride 1.1 MG Chewable Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assodium fluoride 1.1 MG (fluoride ion 0.5 MG) Chewable Tablet
FDA products mapped9
Package NDCs mapped11
Reported Medicaid activity (SDUD)78,889 prescriptions · 34 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Sodium fluoride 1.1 MG Chewable Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sodium fluoride 1.1 MG Chewable Tablet RxCUI 313036

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Sodium fluoride 9873
  2. Brand names 4

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Epiflur 894943
    • Fluoritab 861718
    • Ludent 901277
    • Nafrinse 352784
  3. Dose forms 24

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sodium fluoride Chewable Tablet 373907
    • Sodium fluoride Chewable Product 1295174
    • Sodium fluoride Oral Product 1159341
    • Sodium fluoride Pill 1159343
    • Sodium fluoride Chewable Tablet [Epiflur] 894945
    • Sodium fluoride Chewable Tablet [Fluoritab] 861723
    • Sodium fluoride Chewable Tablet [Ludent] 901279
    • Sodium fluoride Chewable Tablet [Nafrinse] 1302366
    • +16 more in this family
  4. Clinical & branded drugs 9

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Sodium fluoride 1.1 MG 330228
    • Sodium fluoride 1.1 MG Chewable Tablet [Epiflur] 999479
    • Sodium fluoride 1.1 MG Chewable Tablet [Fluoritab] 861724
    • Sodium fluoride 1.1 MG Chewable Tablet [Ludent] 901288
    • Sodium fluoride 1.1 MG Chewable Tablet [Nafrinse] 1302368
    • Sodium fluoride 1.1 MG [Epiflur] 999478
    • Sodium fluoride 1.1 MG [Fluoritab] 861722
    • Sodium fluoride 1.1 MG [Ludent] 901287
    • +1 more in this family

Showing up to 8 concepts per family — 21 of 38 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sodium fluoride 1.1 MG SCDC · 330228
  • Sodium fluoride Chewable Tablet SCDF · 373907
  • Sodium fluoride Chewable Product SCDG · 1295174
  • Sodium fluoride Oral Product SCDG · 1159341
  • Sodium fluoride Pill SCDG · 1159343

Brand-Name Concepts

  • Sodium fluoride 1.1 MG Chewable Tablet [Epiflur] SBD · 999479
  • Sodium fluoride 1.1 MG Chewable Tablet [Fluoritab] SBD · 861724
  • Sodium fluoride 1.1 MG Chewable Tablet [Ludent] SBD · 901288
  • Sodium fluoride 1.1 MG Chewable Tablet [Nafrinse] SBD · 1302368
  • Sodium fluoride 1.1 MG [Epiflur] SBDC · 999478
  • Sodium fluoride 1.1 MG [Fluoritab] SBDC · 861722
  • Sodium fluoride 1.1 MG [Ludent] SBDC · 901287
  • Sodium fluoride 1.1 MG [Nafrinse] SBDC · 1302365
  • Sodium fluoride Chewable Tablet [Epiflur] SBDF · 894945
  • Sodium fluoride Chewable Tablet [Fluoritab] SBDF · 861723

📦 FDA Products & Package NDCs

9 products · 11 package NDCs
11 package NDCs map to RxCUI 313036 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
58657-0160-12 120 TABLET in 1 BOTTLE (58657-160-12) Sodium Fluoride Chewable Method Pharmaceuticals, LLC 2018-08-17
58657-0161-10 1000 TABLET in 1 BOTTLE (58657-161-10) Sodium Fluoride Chewable Method Pharmaceuticals, LLC 2018-08-17
58657-0161-12 120 TABLET in 1 BOTTLE (58657-161-12) Sodium Fluoride Chewable Method Pharmaceuticals, LLC 2018-08-17
58657-0162-12 120 TABLET in 1 BOTTLE (58657-162-12) Sodium Fluoride Chewable Method Pharmaceuticals, LLC 2018-08-17
63629-1131-01 1000 TABLET in 1 BOTTLE (63629-1131-1) Sodium Fluoride Chewable Bryant Ranch Prepack 2018-08-17
63629-1132-01 120 TABLET in 1 BOTTLE (63629-1132-1) Sodium Fluoride Chewable Bryant Ranch Prepack 2020-10-21
72162-1653-00 1000 TABLET in 1 BOTTLE (72162-1653-0) Sodium Fluoride Chewable Bryant Ranch Prepack 2018-08-17
72162-1653-02 120 TABLET in 1 BOTTLE (72162-1653-2) Sodium Fluoride Chewable Bryant Ranch Prepack 2018-08-17
75826-0163-20 120 TABLET, CHEWABLE in 1 BOTTLE (75826-163-20) Fluoride WINDER LABORATORIES, LLC 2024-01-01
75826-0164-20 120 TABLET, CHEWABLE in 1 BOTTLE (75826-164-20) Fluoride WINDER LABORATORIES, LLC 2024-01-01
75826-0165-20 120 TABLET, CHEWABLE in 1 BOTTLE (75826-165-20) Fluoride WINDER LABORATORIES, LLC 2024-01-01
Observed labelers: Bryant Ranch Prepack (4) · Method Pharmaceuticals, LLC (4) · WINDER LABORATORIES, LLC (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.